Summary.-An attempt has been made to construct an assay potentially suitable for use with primary cultures of human tumours to measure the survival of exponentially growing monolayer cultures after exposure to anti-neoplastic drugs. Cell survival was assessed using their protein synthetic capacity after removal of drugs. HeLa cells were employed to avoid the inherent variability and heterogeneity of primary cultures from human tumours, and an assay has been constructed using microtitration trays to provide large numbers of replicate cultures without the requirement of a large number of cells. An increase in the duration of the exposure to drug increased sensitivity in nearly all cases examined. Similarly, an increase in the period of culture following drug removal produced increased sensitivity to alkylating agents but allowed recovery from exposure to certain cycle-dependent drugs.
CYTOTOXICITY of anti-neoplastic drugs in vitro has been used to assess their likely relative potencies in clinical treatment (Limburg and Heckman, 1968; Jzsak et al., 1971) , and in animal experiments (Morasca et al., 1972; Ogawa, Bergsagel and McCulloch, 1973) . There are numerous possible sources of error in this type of screening, including variations in the proportions of different cell types in tissue samples and difficulty in the selection of assay conditions which will give an accurate indication of the sensitivity of the cells to the drugs tested. The relative in vitro colony forming ability of treated and untreated cell samples is the most commonly used method of assessing drug sensitivity. Although this method has considerable advantages, it is not readily applied to primary cultures of human tumours due to their very low cloning efficiency and the slow growth rate of the clones.
The adoption of an assay using monolayer cultures, based on their proliferation ability alone, requires extensive cell counting and would become extremely unwieldy where large numbers of samples are used. The metabolic inhibition test, as used in virus assay (Rosenthal and Shechmeister, 1973 ) is quicker and capable of handling very large numbers of samples. The major difference in this type of test is that metabolic activity is measured rather than proliferation. Protein synthesis was selected in this case as a fundamental metabolic process without which the cell will not survive. 3H-leticine incorporation was used as an index of protein synthesis. As leucine is an essential amino acid, it is unlikely that protein synthesis could continue for long, unimpaired, without leucine incorporation. Hence the absence of protein synthesis, particularly several hours after removal of drug, will almost certainly correlate with cell death.
The relative importance of technical aspects of the assay procedure was suggested by some variations in preliminary results with cultures from human tumour biopsies (Freshney and Paul, 1974 In later experiments, the dlerivation of these values has been automiated usinlg a punched tape output firom the scinitillationi counter and analysing the tape on a Wang desk-top computer. The author-s al e indebted to Dr Bryani Youing of this Inistituite f'or the provision of a progralnme for this operation.
RESULTS

Stability and mietabolismii of dr a,ys dia rii y incubation
To test for dlegradatioin of cIruigs 4 microtitre plates were set up, 2 containing cells at 5 x 103/well (5 x 104/ml) and Ino drugs (assay plates), one coIntaining serial diluitions of 5 drugs but ino cells (drug preincubation plate), aind one containing medium only (medium preincubation plate). After 24 h the meditum from one assay plate wvas discarded andI replaced with thle medium from the drtug preincubation plate. The medium from the secon(l assay plate wN-as removed and(l replaced with mnediutmn from the meedium (JO (Hussa and Pattillo, 1970) and the cytotoxicity of 6-mercaptopurine (Tidd et The effect of varying the length of the recovery period on the estimated ID50 was examined. After removing the drugs, fresh medium was added and changed every 3 days. Samples were taken at 0, 1, 2, 5 and 9 days after removal of the drugs. A continuous decrease in the ID50 was observed for chlorambucil, thiotepa and mustine over the first 5 days (Fig. 4a) . Thereafter these drugs showed no further decreases. The ID50s of mercaptopurine, thioguanine and vinblastine increased rapidly (vinblastine by 8 orders of magnitude) (Fig.  4b) , implying reversal of the cytotoxic action of the drugs or overgrowth of less sensitive cells.
The data from methotrexate are different from the patterns exhibited by the other drugs, showing partial recovery of protein synthesis between 24 and 48 h after removal of the druigs, followed by a rapid fall after 5 days.
C(ell density and drgu sensitivity During preliminary investigations of the drug sensitivity of primary cell strains from human tumour biopsies, large differences in ID50 were detected which could be attributed to changes in cell density (Freshney and Paul, 1974) .
To examine the effect of varying the cell density on the cytotoxicity of mustine, ID50s were determined in a range of densities from 2 x 104 cells/mm2 down to 200 cells/mm 2. The plot of ID50 against cell density (Fig. 5) at 5 x 104 cells/ml (104/well) and grown for 24 h. Drugs were then added for 24 h, after which one plate was labelled (as in Fig. 3 ) and the remainder maintained in culture for a further 1, 2, 5 and 9 days, before labelling. After labelling the cells were washed, the protein extracted and counted and the ID50S calculated. They are plotted semi-log against time. In (b) the lefthand vertical axis refers to MP, TG and MT and the right hand to VB. Abbreviations as in Table I .
DISCUSSION
The object of this work has been to study some of the potential variations to which in vitro assays are subject and, perhaps, to indicate ways of minimizing these variations.
One of the problems of any drug sensitivity measurement is that of alteration of the drug, by metabolism or 7 degradation. Some drugs, e.g. mustine and chlorambucil, were shown to be unstable whereas thiotepa was not. Vinblastine, though stable in the medium, was actively metabolized in the presence of HeLa cells. When these findings are compared with the changes in ID50 with time of exposure to drugs, it can be observed that the two unstable drugs, After 24 h exposure mustine was removed and the cells allowed to recover for 4 h. They were then labelled overnight (18 h) with 10 SiCi/ml 3H-leucine, processed as in Fig. 2 Although all the graphs in Fig. 3 imply a cumulative effect of the drugs with increasing exposure time, the reasons may differ among drugs. While repeated application of alkylating agents may simply increase the amount incorporated, repeated exposures to the cycle dependent drugs will exposure fractions of the population previously resistant, due to their position in the cell cycle. However, the change in response to cycle dependent drugs with increasing time should diminish after the time required for the whole population to go through the cell cycle. Since this is not so, it must be assumed that a dosing effect, similar to the alkylating agents, is in operation and for each successive treatment more analogue is incorporated and cytotoxicity increases. Extended drug exposure may also influence the cytotoxicity of drugs such as cyclophosphamide, which require to be metabolized Sladek, 1973) . In the present experiments cyclophosphamide, which has a very high ID50 after 24 h exposure, shows relatively little increase in cytotoxicity with increased exposure time. This rate of increase in cytotoxicity is less than with any other alkylating agent and may imply that HeLa cells do not oxidize cyclophosphamide so efficiently. Preinctubation of cyclophosphamide with HeLa cells before use did give a reduced ID50 (Table II) but only by about 40%o.
This suggests that the in vitro assessment of cyclophosphamide sensitivity may be inaccurate unless the drug is activated.
Although the effect of the alkylating agents appears to be irreversible, and prolonged culture after their removal increases their apparent cytotoxicity, the toxic effect of anti-metabolites such as 6-mercaptopurine and thioguanine shows apparent reversal. It is not possible to distinguish in this assay between reversibility at the biochemical level and overgrowth by resistant cells. The effect of either is to cause an increase in 3H-leucine incorporation per well, relative to the control, which tends to shift the ID50 to a higher drug concentration. Since the anti-metabolic activity of 6-mercaptopurine is mediated via competitive enzyme inhibition, muLch of its effect would be expected to be reversible and this may be the case. Although a component of the cytotoxicity of thioguanine may result from its inicorporation as a base analogue into DNA (Alexander, Connors and Marbaix, 1971 ) and wotuld be irreversible, some of the cytotoxicity reported here may result from incorporation into RNA (Alexander et al., 1971) and may be reversible.
Since the action of Vinca alkaloids at relatively o0W concentrations is phasespecific, the reversal of vinblastine activity may be produced partly by overgrowth of cells in a resistant phase of the cycle during exposure. The action of vinblastine is also freely reversible (Connors, 1971) Fig. 4 that those drugs which show reversal of cytotoxicity are those that are cycle dependent); (vi) attainment of confluence and density limited conditions during or after exposure.
In addition to the effects of a change in cell density during the assay, the initial cell density at the time of drug ad(ldition will also affect the resuilts. As can be seen from Fig. 5 , cells which are already in a density limited state may be much less sensitive to certain drugs. This may be correlated directly with the rate of DNA synthesis, as suiggested in Fig. 5 , or may be duie to differences in membrane permeability (Goldeniberg et al., 1971) . The observation that mutstine degradation does not increase in the presence of a high cell concentration (see above) suggests that metabolism of the drug is not a major influence on the ID50. In spite of the fact that the culture medium was replaced daily, the possibility of a gradually increasing proportion of cells of low viability produced by overcrowding cannot be discouinted.
It is important that some account be taken of the variation described above in aniy attempt to use in vitro assay for predictive drug screening. It may, in fact, be difficult to devise a standard techniique for all cytotoxic agents but the most satisfactory compromise may be to design the test system such that (1) exposure to drug covers at least 2 cell cycles, (2) conditions are selected such that control cultures maintain logarithmic growth throughout the assay and (3) sufficient time is allowed for (lelayed cytotoxicity to be expressed. 
